Antibody (3)
Launched (3)
Mouse (3)
- (1)Human IgG1 (2)
Unconjugated (3)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
RSV-MY2189 | HEK293 | Monoclonal Anti-RSV(B)-Pre-F0 Antibody, Mouse IgG1 (7B2) (MALS verified) | ||||
RSV-MY2202 | HEK293 | Monoclonal Anti-RSV(B)-Pre-F0 specific Antibody, Human IgG1 (4H8) (MALS verified) | ||||
RSV-MY2246 | HEK293 | Monoclonal Anti-RSV(B)-Pre-F0 specific Antibody, Human IgG1 (8E3) (MALS verified) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| NG-641 | EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAP | Phase 1 Clinical | Akamis Bio Ltd, University Of Oxford | Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Neoplasm Metastasis | Details |




